Pyrvinium: Difference between revisions
Content deleted Content added
ClueBot NG (talk | contribs) m Reverting possible vandalism by FadyTakla to version by Tea with toast. False positive? Report it. Thanks, ClueBot NG. (102864) (Bot) |
No edit summary Tag: categories removed |
||
| Line 1: | Line 1: | ||
Pyrvinium (Oral-Local) |
|||
{{expand|date=December 2010}} |
|||
{{unreferenced|date=December 2010}} |
|||
{{Drugbox |
|||
| IUPAC_name = 2-[(''E'')-2-(2,5-Dimethyl-1-phenylpyrrol-3-yl)ethenyl]-''N'',''N'',1-trimethylquinolin-1-ium-6-amine |
|||
| image = Pyrvinium.png |
|||
| CAS_number = 7187-62-4 |
|||
| ATC_prefix = P02 |
|||
| ATC_suffix = CX01 |
|||
| PubChem = 5281035 |
|||
| DrugBank = |
|||
| C=26|H=28|N=3|charge=+ |
|||
| molecular_weight = 382.52 g/mol |
|||
| bioavailability = |
|||
| protein_bound = |
|||
| metabolism = |
|||
| elimination_half-life = |
|||
| excretion = |
|||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
| pregnancy_US = <!-- A / B / C / D / X --> |
|||
| pregnancy_category= |
|||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|||
| legal_status = |
|||
| routes_of_administration = |
|||
}} |
|||
VA CLASSIFICATION |
|||
'''Pyrvinium''' is an [[anthelmintic]]. |
|||
Primary: AP200{03} |
|||
Commonly used brand name(s): Vanquin. |
|||
{{Anthelmintics}} |
|||
Another commonly used name is |
|||
[[Category:Anthelmintics]] |
|||
viprynium . |
|||
| ⚫ | |||
Note: For a listing of dosage forms and brand names by country availability, see Dosage Forms section(s). |
|||
[[Category:Quinolines]] |
|||
[[Category:Quaternary ammonium compounds]] |
|||
*Not commercially available in the U.S. |
|||
{{antiinfective-drug-stub}} |
|||
[[de:Pyrvinium]] |
|||
| ⚫ | |||
[[sv:Pyrvin]] |
|||
Anthelmintic (oral-local)— |
|||
Indications |
|||
Note: Because pyrvinium is not commercially available in the U.S., the use of brackets in this monograph reflects the lack of labeled (approved) indications for this medication. |
|||
Accepted |
|||
[Enterobiasis (treatment)]—Pyrvinium is used in the treatment of enterobiasis caused by Enterobius vermicularis (pinworm). {07} However, pyrvinium has generally been replaced by other anthelmintics (e.g., mebendazole or pyrantel). |
|||
Revision as of 23:30, 7 December 2010
Pyrvinium (Oral-Local)
VA CLASSIFICATION Primary: AP200{03}
Commonly used brand name(s): Vanquin.
Another commonly used name is viprynium . Note: For a listing of dosage forms and brand names by country availability, see Dosage Forms section(s).
- Not commercially available in the U.S.
Category:
Anthelmintic (oral-local)—
Indications
Note: Because pyrvinium is not commercially available in the U.S., the use of brackets in this monograph reflects the lack of labeled (approved) indications for this medication.
Accepted
[Enterobiasis (treatment)]—Pyrvinium is used in the treatment of enterobiasis caused by Enterobius vermicularis (pinworm). {07} However, pyrvinium has generally been replaced by other anthelmintics (e.g., mebendazole or pyrantel).